Hydroxyurea vindicated: lack of drug leukemogenicity in polycythemia vera
Tefferi, A.
Current Hematology Reports 4(3): 211-212
2005
ISSN/ISBN: 1541-0714 PMID: 15865873 Document Number: 585695
Document emailed within 1 workday
Related Documents
Fruchtman, S.M.; Mack, K.; Kaplan, M.E.; Peterson, P.; Berk, P.D.; Wasserman, L.R. 1997: From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera Seminars in Hematology 34(1): 17-23Kaplan, M.E.; Mack, K.; Goldberg, J.D.; Donovan, P.B.; Berk, P.D.; Wasserman, L.R. 1986: Long-term management of polycythemia vera with hydroxyurea: a progress report Seminars in Hematology 23(3): 167-171
Najean, Y. 1992: Treatment of polycythemia vera with hydroxyurea or pipobroman. Efficacy and toxicity analysed from a protocol of 96 patients under 65 years of age. Le Groupe d'Etude des Polyglobulies Presse Medicale 21(37): 1753-1757
Meytes, D.; Shacked, N.; Padeh, B.; Czerniak, P.; Pinkhas, J.; Ramot, B. 1972: Immunoglobulin levels in polycythemia vera, erythrocytosis, secondary polycythemia and myelofibrosis Israel Journal of Medical Sciences 8(7): 925-931
Rorvik, T.O. 1974: Polycythemia vera Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 94(32): 2260-2263
Reed, C.; Ling, G.V.; Gould, D.; Kaneko, J.J. 1970: Polycythemia vera in a cat Journal of the American Veterinary Medical Association 157(1): 85-91
Plomley, R.F.; Sullivan, J.R.; Whitworth, J.A.; Kincaid-Smith, P.S.; Fairley, K.F.; Brown, R.W. 1983: Polycythemia vera and glomerulonephritis Australian and New Zealand Journal of Medicine 13(2): 125-129
Fernandez-Luna, J.L.; Silva, M.; Richard, C.; Sanz, C.; Benito, A. 1998: Pathogenesis of polycythemia vera Haematologica 83(2): 150-158
Shan, Y.D.; Liu, E.K.; Li, R.S. 1990: Various transformations of polycythemia vera Zhonghua Nei Ke Za Zhi 29(1): 19-21; 60
Mork, J.N.; Barlow, J.F. 1978: Multiple thromboses in polycythemia vera Minnesota Medicine 61(4): 209-210
Parmentier, C.; Gardet, P. 1994: The use of 32 phosphorus (32P) in the treatment of polycythemia vera Nouvelle Revue Francaise d'Hematologie 36(2): 189-192
Hör, G.; Pabst, H.W. 1973: Radiophosphorus therapy of polycythemia vera Therapeutische Umschau. Revue Therapeutique 30(11): 789-796
Pérez Castrillón, J.L.; Cruz Vicente, J.M.; Benítez Domínguez, J.A.; Escudero Sereno, V. 1989: Polycythemia vera and factor Xi deficiency Anales de Medicina Interna 6(6): 337
Ellis, J.T.; Peterson, P. 1979: The bone marrow in polycythemia vera Pathology Annual 14 Pt 1: 383-403
Komatsu, N. 2012: Pathogenesis and treatment of polycythemia vera Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 2): 314-320
Mesa, R.A. 2017: New guidelines from the NCCN for polycythemia vera Clinical Advances in Hematology and Oncology: H&o 15(11): 848-850
Fischer, H. 1985: Leukergy-stimulating factors in polycythemia vera Folia Haematologica 112(4): 580-586
Tesselaar, M.E.; Wijermans, P.W.; Metsaars, J.A.; Gerrits, W.B.; Haak, H.L. 1996: Radioactive phosphorus (32P); an old but not bad treatment for polycythemia vera Nederlands Tijdschrift Voor Geneeskunde 140(38): 1900-1902
Gelfand, M.L. 1992: Bilateral adrenal hemorrhage in polycythemia vera New York State Journal of Medicine 92(8): 362-363
Steensma, D.P. 2005: Polycythemia vera: plethora, from prehistory to present Current Hematology Reports 4(3): 230-234